CML Chronic Myeloid Leukemia

www.welooktoyou.com

In this short documentary, Dr. Janet D. Rowley shares the journey that brought her to the discovery of the 9;22 translocation in chronic myelogenou...

In this short documentary, Dr. Janet D. Rowley shares the journey that brought her to the discovery of the 9;22 translocation in chronic myelogenou...

Dr. Janet D. Rowley, who determined that the Philadelphia Chromosome was a translocation of material from chromosomes 9 and 22, shares her thoughts...

Dr. Janet Rowley, responsible for determining the 9;22 translocation in CML, shares a brief word to our community as we approach CML Awareness Day ...

MD Anderson researchers play crucial role in two New England Journal of Medicine studies showing newer drugs for chronic myeloid leukemia work fas...

Dr. Sonali Smith discusses treatment innovations for CML.

Dr. Sonali Smith discusses the newest developments in the treatment of CML.

Dr. Jorge Cortes discusses new data on bosutinib, a new tyrosine kinase inhibitor for CML.

While recent years has brought the breakthrough medicine Gleevec for CML and this year two new frontline medicines, some patients still need better...

What is PCR - Polymerase Chain Reaction, and how it is used to monitor CML.

President Obama honors this years recipients of the Presidential Medal of Freedom, Americas highest medal awarded to civilians, during a reception ...

Janet D. Rowley, M.D., D.Sc. the Blum-Riese Distinguished Service Professor in the departments of medicine, molecular genetics and cell biology, an...

A pioneer in cancer science, Janet Rowley received the Presidential Medal of Freedom from President Barack Obama at a White House ceremony on Augus...

http://www.uchospitals.edu/...

Janet Davidson Rowley, MD, is recognized as a leader in cancer research and is an authori...

'D.O.C. The Media Medic' and Kareem Abdul Jabbar discuss Philadelphia Positive Chronic Myelogenous Leukemia on Hollywood Health News TV.

The 2009 Lasker Awards honor six visionaries whose insight and courage has led to dramatic advances that will prevent disease and prolong life.

Hope Funds for Cancer Research Awards Gala 2009

Dr. Brian Druker, the driving force behind Gleevac, a life saving drug for people affected by Chronic Myeloid Leukemia, focuses his attention on ho...

Dr. Brian Drucker discusses cancer treatment Gleevac

www.charlierose.com

Imatinib has become the paradigm of targeted drug development. The lessons learned from the clinical trials of imatinib treatment of chronic myeloi...

Imatinib (Gleevec) has become a paradigm for targeted cancer therapies. Although the majority of patients with chronic myeloid leukemia (CML) resp...

Imatinib (Gleevec) has become a paradigm for targeted cancer therapies. The first part of this lecture will describe the clinical features and the ...

Diagnosed six years earlier with chronic myelogenous leukemia, a cancer of the blood, Doug, now age 75, was told there was nothing the doctors coul...

The University of Michigan's Dr. Moshe Talpaz, a renowned CML expert, gives his views on combination therapy for CML and the prospect that some pat...

Dr. Neil Shah discusses the new landscape of current and promising investigational medicines for CML and comments on the possibilities of combinati...

Dr. Alison Loren from Penn Medicine gives her views on a treatment approaches for CML and CLL.

The founder of OHSU's Knight Cancer institute celebrates the progress in personalized medicine for cancer patients and cites the development of Gle...

The National CML Society was created by and for Chronic Myelogenous Leukemia survivors and their families in order to provide a centralized hub of ...

The National CML Society was created by and for Chronic Myelogenous Leukemia survivors and their families in order to provide a centralized hub of ...

The National CML Society was created by and for Chronic Myelogenous Leukemia survivors and their families in order to provide a centralized hub of ...

The National CML Society was created by and for Chronic Myelogenous Leukemia survivors and their families in order to provide a centralized hub of ...